Category
Services
Modalities
Indications
Phases
Sourcing
Locations
Certifications
High-Throughput Screening, Medicinal Chemistry, Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Translational Research, Microbiology Services, Virology Services, Immunology & Inflammation Services, Oncology Specialty Services, CNS Specialty Services, Cardiovascular & Metabolic Specialty Services, Device & Combination Product Services
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Oligonucleotide, Cell Therapy, Gene Therapy, Peptide, Vaccine, Radiopharmaceutical
Oncology, Immunology, Neurology, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Ophthalmology, Gastroenterology
Preclinical (General), Phase I, Phase II, Phase III, Phase IV, Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Headquarters, Hangzhou, Zhejiang, China, Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)
—
Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule), Immunogenicity Assays (ADA / NAb), Biomarker Assays, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Pharmacovigilance & Drug Safety, Medical Writing, Central Laboratory Services, Clinical Imaging Core Lab, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Microbiology Services, Virology Services, Immunology & Inflammation Services, Oncology Specialty Services, CNS Specialty Services, Cardiovascular & Metabolic Specialty Services, Device & Combination Product Services
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Vaccine, Radiopharmaceutical
Oncology, Immunology, Neurology, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Phase I, Phase II, Phase III, Phase IV
Full-Service Outsourcing (FSO)
Central Laboratories, Cincinnati, Ohio, United States, Central Laboratory, Cincinnati, Ohio, United States, Headquarters, Cincinnati, OH, USA, Dallas, Irving, TX, USA, Denver, Denver, CO, USA, Mexico City, Mexico City, Distrito Federal, Mexico, Leuven, Leuven, Flemish Brabant, Belgium, Prague, Prague, Prague, Czech Republic, Copenhagen, Copenhagen, Copenhagen, Denmark, Lyon, Lyon, Auvergne-Rhône-Alpes, France, Munich, Munich, Bavaria, Germany, Budapest, Budapest, Budapest, Hungary, Rehovot, Rehovot, Central, Israel, Milan, Milan, Lombardy, Italy, London, London, England, United Kingdom, Maastricht, Maastricht, Limburg, Netherlands, Rotterdam, Rotterdam, South Holland, Netherlands, Warsaw, Warsaw, Masovian, Poland, Johannesburg, Johannesburg, Gauteng, South Africa, Dallas, Dallas, TX, USA, Madrid, Madrid, Spain, Mexico, Mexico City, Mexico City, Mexico
—
Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Genetic Toxicology, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Specialized & Large-Animal Models, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Immunogenicity Assays (ADA / NAb), Biomarker Assays, Flow Cytometry Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Medical Writing, Central Laboratory Services, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Translational Research, Companion Diagnostics Development, Microbiology Services, Virology Services, Immunology & Inflammation Services, Oncology Specialty Services, CNS Specialty Services, Cardiovascular & Metabolic Specialty Services, Pathology & Histology Services, Genomics & Sequencing Services
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, Vaccine, Radiopharmaceutical
Oncology, Immunology, Neurology, Psychiatry, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Women's Health
Preclinical (General), Preclinical (IND-Enabling), Phase I, Phase II, Phase III, Phase IV
Full-Service Outsourcing (FSO)
Global Operations, Global
—
Discovery Research, Target Identification & Validation, High-Throughput Screening, Medicinal Chemistry, Computational & In-Silico Drug Discovery, Preclinical In Vitro Studies, In Vitro Pharmacology, In Vitro ADME / DMPK, Safety Pharmacology, Genetic Toxicology, Preclinical In Vivo Studies, In Vivo Efficacy Models, In Vivo PK / PD Studies, GLP Toxicology, Bioanalysis, LC-MS Bioanalysis (Small Molecule), Ligand-Binding Bioanalysis (Large Molecule), Biomarker Assays, Clinical Trial Services, Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV / Post-Marketing, Clinical Operations, Data Management & eClinical, Biostatistics & Statistical Programming, Medical Writing, Regulatory Affairs, US FDA Regulatory Strategy, EU EMA Regulatory Strategy, Japan PMDA Regulatory Strategy, China NMPA Regulatory Strategy, Translational Research
Small Molecule, Biologics (Monoclonal Antibodies), Biologics (Other), Antibody-Drug Conjugate (ADC), Oligonucleotide, mRNA, Cell Therapy, Gene Therapy, Peptide, Vaccine
Oncology, Immunology, Neurology, Psychiatry, Metabolic, Cardiovascular, Infectious Disease, Rare Disease, Respiratory, Dermatology, Ophthalmology, Gastroenterology, Nephrology, Women's Health
Discovery, Preclinical (General), Phase I, Phase II, Phase III, Phase IV, Preclinical (IND-Enabling), Real-World Evidence (RWE) / Registries
Full-Service Outsourcing (FSO), Functional Service Provider (FSP)
Global network, Global presence, 30 countries, Global presence, Multiple, 30 countries, Global, Global presence, Multiple, 30+ countries, Global presence, Multiple, 30 countries, International, Headquarters, Radnor, Pennsylvania, United States, Global presence, 30 countries, Global presence, 30+ countries
—
Showing three peers in the matrix — full ranked list is above.